Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Non-Current AssetsPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Long Term DebtTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abivax (ABVX) Total Liabilities: 2021-2024

Historic Total Liabilities for Abivax (ABVX) over the last 4 years, with Dec 2024 value amounting to $168.7 million.

  • Abivax's Total Liabilities fell 81.75% to $80.8 million in Q2 2025 from the same period last year, while for Jun 2025 it was $80.8 million, marking a year-over-year decrease of 81.75%. This contributed to the annual value of $168.7 million for FY2024, which is 26.14% up from last year.
  • Latest data reveals that Abivax reported Total Liabilities of $168.7 million as of FY2024, which was up 26.14% from $133.7 million recorded in FY2023.
  • Abivax's Total Liabilities' 5-year high stood at $168.7 million during FY2024, with a 5-year trough of $68.8 million in FY2022.
  • Over the past 3 years, Abivax's median Total Liabilities value was $133.7 million (recorded in 2023), while the average stood at $123.7 million.
  • Per our database at Business Quant, Abivax's Total Liabilities decreased by 27.46% in 2022 and then spiked by 94.35% in 2023.
  • Over the past 4 years, Abivax's Total Liabilities (Yearly) stood at $94.8 million in 2021, then fell by 27.46% to $68.8 million in 2022, then spiked by 94.35% to $133.7 million in 2023, then rose by 26.14% to $168.7 million in 2024.